[Pharmacological treatment reduces mortality in COPD]. / Behandling med läkemedel kan reducera mortaliteten vid KOL.
Lakartidningen
; 1192022 01 12.
Article
en Sv
| MEDLINE
| ID: mdl-35020190
ABSTRACT
Approximately 500 000 individuals in Sweden have chronic obstructive pulmonary disease (COPD). Co-morbid, especially cardiovascular, conditions are common in COPD and globally COPD is the third most common cause of mortality. Mortality in COPD is driven by dyspnea, exacerbations and comorbidities and is reduced by smoking cessation and lung rehabilitation. Also, pharmacological treatment, in particular inhaled corticosteroids, reduces mortality in COPD. The reduction in mortality that can be achieved by treatment with inhaled corticosteroids in combinations with long-acting bronchodilators is of the same order of magnitude as the effect on mortality by treatment of hyperlipidemia and hypertension.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
6_chronic_obstructive_pulmonary_disease
/
6_other_respiratory_diseases
Asunto principal:
Cese del Hábito de Fumar
/
Enfermedad Pulmonar Obstructiva Crónica
Límite:
Humans
Idioma:
Sv
Revista:
Lakartidningen
Año:
2022
Tipo del documento:
Article